Prolonged vecuronium neuromuscular blockade in a patient receiving orally administered dantrolene.
Driessen
J J
JJ
Wuis
E W
EW
Gielen
M J
MJ
D003620:Dantrolene / Q000009:adverse effects*; D004347:Drug Interactions; D004576:Electromyography; D005260:Female; D006801:Humans; D008305:Malignant Hyperthermia / Q000517:prevention & control*; D008875:Middle Aged; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology*; D010197:Pancuronium / Q000031:analogs & derivatives* / Q000494:pharmacology; D013997:Time Factors; D014673:Vecuronium Bromide
D009466:Neuromuscular Blocking Agents; D014673:Vecuronium Bromide; D003620:Dantrolene; D010197:Pancuronium